Bollard Group LLC - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 63 filers reported holding CIDARA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$6,000
-40.0%
7,7330.0%0.00%
Q4 2021$10,000
-41.2%
7,7330.0%0.00%
-100.0%
Q3 2021$17,000
+6.2%
7,7330.0%0.00%0.0%
Q2 2021$16,000
-23.8%
7,7330.0%0.00%0.0%
Q1 2021$21,000
+40.0%
7,7330.0%0.00%0.0%
Q4 2020$15,000
-31.8%
7,7330.0%0.00%0.0%
Q3 2020$22,000
-24.1%
7,7330.0%0.00%0.0%
Q2 2020$29,0007,7330.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,627,670$1,533,5911.88%
5AM Venture Management, LLC 1,134,511$1,068,9360.31%
Nantahala Capital Management 2,538,406$2,391,6860.20%
BVF INC/IL 6,861,127$6,464,5540.17%
Monashee Investment Management LLC 369,099$347,7650.14%
West Family Investments, Inc. 368,910$347,5870.12%
JEPPSON WEALTH MANAGEMENT, LLC 137,560$129,6090.06%
XTX Topco Ltd 202,758$191,0390.03%
GSA CAPITAL PARTNERS LLP 136,974$1290.01%
Callan Capital, LLC 103,462$97,4820.01%
View complete list of CIDARA THERAPEUTICS INC shareholders